SCIENTIFIC PROGRAMME

REGISTRATION 8.30 a.m. – 9.15 a.m. (CEST)

CONFERENCE 9.15 a.m. – 6.00 p.m. (CEST)

08:30 – 09:15Registration
09:15 – 09:30Institutional Greetings
09:30 – 10:45Plenary Session Theranostics in Glioblastoma Precision Medicine: The Dark and Bright Sides of the Moon
 Chair: Concettina La Motta
 From Fluorescence-Guided Neurosurgery to Theranostics for High-Grade Gliomas: Clinical and Experimental Examples
Lorenzo Magrassi, Neurosurgery, Department of Clinical, Surgical, Diagnostic and Pediatric Science, University of Pavia, Pavia
 Targeting ALDH1A3: Drug Discovery Strategies for Next-Generation Theranostics
Silvia Garavaglia, Department of Scienze del Farmaco, University of Piemonte Orientale, Novara
 Computational Investigation of Benzaldehyde-Based Inhibitors of ALDH1A3 for Theranostic Applications
Nicolò Mesano, Department of Biotechnology, Chemistry and Pharmacy, University of Siena, Siena
10:45 – 11:15Coffee break and Networking
 Session 1 – Chemical Strategies and Molecular Tools
 Chairs: Lorenzo Magrassi and Conxettina La Motta
11:15 – 11:45The Purinergic P2X7 Receptors in Gliomas: Development of Molecular Imaging Tools
Enza Lacivita, Department of Pharmacy, Drug Sciences, University of Bari Aldo Moro, Bari
11.45 – 12:00Dual Inhibitors of NAMPT and CAs IX and XII: A Multitarget Approach Against Glioblastoma
Alessio Nocentini, Department of NEUROFARBA, University of Florence, Florence
12:00 – 12:15Development of Peptide Drug Conjugates Targeting the Apelin Receptor for Theranostic Applications
Lidia Ciccone, Department of Pharmacy, University of Pisa, Pisa
12:15 – 12:30Small Luminescent Molecules: Lighting Up the Way
Chiara Gangemi, Department of Chemical, Biological, Pharmaceutical and Environmental Sciences, University of Messina, Messina
12:30 – 12:45Fluorescent Ligands for Target Identification and Preclinical Drug Screening in Cancer
Maria Majellaro, Celtarys Research SL, Avda., Santiago de Compostela, Spain
12:45 – 14:00Lunch break + E-Poster Showcase & Networking
 Session 2 – Biological Complexity and Clinical Perspectives
 Chairs: Silvia Garavaglia and Enza Lacivita
14:00 – 14:20Hadrontherapy: Current Frontiers to Overcome Tumor Radioresistance
Angelica Facoetti, Centro Nazionale di Adroterapia Oncologica (CNAO), Pavia
14:20 – 14:40Molecular Neuro-Oncology from the Operating Room to the Patient’s Care.
Anna Luisa Di Stefano, Dipartimento di Neurochirurgia, Azienda Ospedaliera Toscana Nord-ovest, Livorno
14:40 – 15:00Beyond the Loss of Function: PTEN Gain-of-Function Mutations Drive Super-Diffusive Migration and Poor Survival in Glioblastoma
Chiara Maria Mazzanti, Fondazione Pisana per la Scienza, Pisa
15:00 – 15:20Theranostic Bioimaging Approaches for Glioblastoma: From Surgical Guidance to Immune Monitoring
Cristina Chirizzi, Department of Neuroradiology, IRCCS Foundation Neurological Institute “Carlo Besta”
15:20 – 15:40Cerebral Open Flow Microperfusion (cOFM) – Interstitial profiling for drug development and precision medicine
Thomas Altendorfer-Kroath, HEALTH – Institute for Biomedical Research and Technologies, Joanneum Research Forschungsgesellschaft mbH, Graz, Austria
15:40 – 16:15Coffee break and Networking
 Session 3 – The Youngers’ Point of View
 Chairs: Ilaria D’Agostino and Nicolò Messano
16:15 – 16:30Engineered PVA Microbubbles for Targeted Drug Delivery to Glioblastoma Vasculature
Alessandra Vitaliti, Department of Chemical Science and Technologies, University of Rome Tor Vergata, Rome, Italy
16:30 – 16:45Biomimetic bEnd.3 Membrane-Coated Liposomes for Enhanced Blood–Brain Barrier Targeting
Siria Emily Nesti, Department of Pharmacy, University of Pisa, Pisa
16:45– 17:00Beyond the brain: circulating tumor cells as a tool for diagnosis and monitoring
Francesca Lessi
, Fondazione Pisana per la Scienza, Pisa
17:00 – 17:15MicroRNAs and Treatment Response in Brain Tumors: Hype, Hope or Clinical Reality?
Aleksandar Stepanovic, Institute for Oncology and Radiology of Serbia, Belgrade, Serbia
17:15 – 17:30Glucoconjugated Cyclopentadienyl Tricarbonyl Rhenium Complex for Infrared Detection of Glycolytic Cancer Cells
Giulia Bononi, Department of Pharmacy, University of Pisa, Pisa
17:30 – 17:45AI-Driven Drug Repurposing for Targeted Therapy and Tumor Biology in Glioblastoma
Francesca Marchetto, Fondazione Pisana Per La Scienza, Pisa
17:45 – 18:00Closing